HROW

Harrow Health Inc
18.71
0.00 (0.00%)

Harrow Health Inc. (HROW) Fundamentals

Harrow Health Inc is an ophthalmology-focused pharmaceutical company. The company is specialized in the development, production, and sale of medications that offer competitive advantages and serve unmet needs in the marketplace. Its cornerstone of ophthalmology program consists of proprietary Dropless Therapy injectable and LessDrops topical formulations that are designed to address patient compliance issues and provide other compelling medical and economic benefits.
SHARE INFORMATION
Market Cap$ 557,372,397
Shares Outstanding29,790,080
Float24,498,500
Percent Float82.24%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 72,476,000
Latest Fiscal EPS$ -0.68
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions165
Institutional Holdings Date2023-01-31
Institutional Bought Previous 3 Months560,426
Institutional Holdings Percent73.4%
Institutional Sold Previous 3 Months1,725,052
Insider Holdings Date2023-01-31
Insider Bought Previous 3 Months596,543
Insider Holdings Percent20.0
Insider Sold Previous 3 Months155,781
Insider Shares Owned5,494,066
TRADING INFO
52 Week High$ 20.31
52 Week Low$ 5.40
52 Week High Change$ 126.51
21 Day Moving Average$ 15.3769
21 Day Extended Moving Average$ 15.8636
50 Day Moving Average$ 13.9007
50 Day Extended Moving Average$ 14.3142
200 Day Moving Average$ 9.9071
200 Day Extended Moving Average$ 11.0928
10 Day Average Volume397,746
20 Day Average Volume290,929
30 Day Average Volume300,239
50 Day Average Volume296,099
Alpha0.050438
Beta0.2120
Standard Deviation0.189075
R20.003668
7 Day Price Change$ 3.54
7 Day Percent Change23.34%
21 Day Price Change$ 4.70
21 Day Percent Change33.55%
30 Day Price Change$ 4.46
30 Day Percent Change31.3%
Month to Date Price Change$ 3.69
Month to Date Percent Change24.57%
Quarter to Date Price Change$ 3.95
Quarter to Date Percent Change26.76%
180 Day Price Change$ 11.89
180 Day Percent Change174.34%
200 Day Price Change$ 11.65
200 Day Percent Change165.01%
Year to Date Price Change$ 3.95
Year to Date Percent Change26.76%

Harrow Health Inc. (HROW) Key Ratios

PROFITABILITY
EBIT Margin-0.8%
EBITDA Margin2.9%
Pre-Tax Profit Margin-8.8%
Profit Margin Count-22.18%
Gross Margin71.4%
Profit Margin TOT-22.18%
INCOME STATEMENTS
Revenue$ 68,266,000
Revenue Per Share$ 2.2916
Revenue (3 Years)$ 11.99
Revenue (5 Years)$ 20.15
FINANCIAL STRENGTH
Price to Tangible Book-27.80
Total Debt To Equity66.10
Int Coverage-3.10
Current Ratio3.50
Leverage Ratio17.30
Quick Ratio3.00
Long Term Debt To Capital0.98
VALUATION MEASURES
PE Ratio-23.20
Enterprise Value$ 604,502,139
Price to Sales8.1647
Price to Free Cash155.80
PE High Last 5 Years0.00
Price To Book471.00
Price To Cash Flow133.50
PE Low Last 5 Years0.00
Price to Tangible Book-27.80
MANAGEMENT EFFECTIVENESS
Receivables Turnover3.80
Invoice Turnover5.10
Assets Turnover0.30
Return Assets-22.36
Return on Equity-253.39
Return on Capital-25.82

Harrow Health Inc. (HROW) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorKMJ Corbin & Company LLP
CEOMark L. Baum
Emplyoees182
Last AuditUQ
CIK0001360214
IndustryDrug Manufacturers
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address102 Woodmont Boulevard
Suite 610
Nashville, TN 37205
Websitehttps://www.harrowinc.com
Facsimile-
Telephone+1 615 733-4730
Emailjpatton@harrowinc.com


Your Recent History
NASDAQ
HROW
Harrow Hea..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.